Jerry Bagel, MD, director of the Psoriasis Treatment Center of New Jersey, sheds light on the clinical utility of newer classes of biologic agents in the management of psoriasis and psoriatic arthritis.
An Interview With Jerry Bagel, MD
Advertisement
Articles by An Interview With Jerry Bagel, MD
Advertisement
Latest Updated Articles
Practical Insights on the Changing Spectrum of Biologic Agents for the Treatment of Patients With Psoriatic DiseasePublished: May 23rd 2020 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Physician Peer Influence Drives Uptake of Opportunistic Salpingectomy for Ovarian Cancer Prevention
2
CAR T-Cell Therapy Holds Potential in SCLC, but Significant Barriers Remain
3
Bispecific Antibodies in Multiple Myeloma Are Moving From Clinical Trials to Community Practice
4
Efgartigimod Outperforms Standard IVIG in Averting Myasthenic Crisis
5
